drugset / Trial / NCT01615198
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to access the efficacy and safety of LCZ696 compared to olmesartan in elderly Asian patients for the treatment of hypertension.
Timeline
- Start
- 2012-08
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LCZ696 | Unknown | 200 mg | — |
| Comparator | Olmesartan | Other / unclassified | 20 mg | — |